Literature DB >> 17673425

Treatment of breast tumor cells in vitro with the mitochondrial membrane potential dissipater valinomycin increases 18F-FDG incorporation.

Tim A D Smith1, Morgan G Blaylock.   

Abstract

UNLABELLED: Mitochondrial membrane potential is essential for adenosine triphosphate (ATP) synthesis by oxidative phosphorylation, and its abolition is an early event during apoptosis, a type of cell death commonly exhibited by tumor cells responding to treatment. Dissipation of mitochondrial membrane potential can be specifically induced using the K+ ion channel-opening agent valinomycin and has been used in this study to determine how the loss of mitochondrial membrane potential could influence 18F-FDG incorporation.
METHODS: MCF-7 cells were treated with valinomycin for 30 min, inducing loss of mitochondrial membrane potential as determined using flow cytometry with the JC-1 probe. 18F-FDG incorporation, the initial rate of O-methyl-D-glucose incorporation (a measure of glucose transport), hexokinase activity and subcellular distribution, ATP content using bioluminescence, and lactate production were determined on control and valinomycin-treated cells.
RESULTS: A 30-min treatment of MCF-7 cells with 1 micromol of valinomycin per liter resulted in absence of red fluorescence from JC-1, indicative of dissipation of mitochondrial membrane potential. 18F-FDG incorporation was significantly increased by 30 min of treatment with valinomycin and was still apparent after 3.5 h of incubation. Hexokinase activity and subcellular distribution were not significantly different between control cells and cells treated for 30 min with valinomycin. Glucose transport was moderately though significantly increased, and lactate production was also increased.
CONCLUSION: Loss of mitochondrial membrane potential is associated with increased 18F-FDG incorporation, glucose transport, and lactate production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673425     DOI: 10.2967/jnumed.107.041665

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion.

Authors:  Aleksandar Rakovic; Jonathan Ziegler; Christoph U Mårtensson; Jannik Prasuhn; Katharina Shurkewitsch; Peter König; Henry L Paulson; Christine Klein
Journal:  Cell Death Differ       Date:  2018-10-30       Impact factor: 15.828

Review 2.  Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection.

Authors:  Subhajit Maity; Abhik Saha
Journal:  Front Microbiol       Date:  2021-05-14       Impact factor: 5.640

3.  [F]fluoro-2-deoxy-d-glucose incorporation by mcf-7 breast tumour cells in vitro is modulated by treatment with tamoxifen, Doxorubicin, and docetaxel: relationship to chemotherapy-induced changes in ATP content, hexokinase activity, and glucose transport.

Authors:  R I Sharma; A E Welch; L Schweiger; S Craib; T A D Smith
Journal:  Int J Mol Imaging       Date:  2010-10-26

4.  HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.

Authors:  Ranganayaki Muralidharan; Meghna Mehta; Rebaz Ahmed; Sudeshna Roy; Liang Xu; Jeffrey Aubé; Allshine Chen; Yan Daniel Zhao; Terence Herman; Rajagopal Ramesh; Anupama Munshi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.